Genmab Showcases Data From Robust Development Program Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients Across a Broad Ran
11/12 23:30
Media Release COPENHAGEN, Denmark; December 1 1 , 2022 Epcoritamab featured in multiple data disclosures , including four oral presentations R esults presented from the phase 1 b /2 EPCORE™ NHL-2 trial of e pcoritamab combined with standard salvage therapy in patients with transplant eligible...